Latest HLA-A Stories
Continued Positive Trends in Overall Survival and Progression-Free Survival; LOS ANGELES, Nov. 14, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
Holotype HLA and other Omixon products are featured across multiple sessions at the ASHI Annual Meeting 2014 in Denver Colorado 20-24 October. Budapest, Hungary
Omixon Holotype HLA is a combination NGS Assay and Software product that provides the most accurate high-resolution, high-throughput HLA genotyping available. Budapest,
Omixon and CHOP have used next-generation sequencing tools to significantly advance HLA typing, characterizing whole genes with variations fully phased. Cambridge,
Pre-specified MGMT and HLA Subgroup Analyses Show Potentially Clinically Meaningful Survival Advantages for ICT-107 Treated Patients LOS ANGELES, June 1, 2014 /PRNewswire/ -- ImmunoCellular
Human HLA genes – the genes that allow our immune system to tell the difference between our own cells and foreign invaders – are evolving much more rapidly than previously thought.
One of the challenges to HIV vaccine development has been the lack of an animal model that accurately reflects the human immune response to the virus and how the virus evolves to evade that response.
Adverse drug reactions are a major issue that cause harm, are costly and restrict treatment options for patients and the development of new drugs.
The great variation of a specific form of immune genes makes organ transplants so complicated. On the other hand, we need such a great variability in order to resist infectious diseases.
Sexual encounters with Neanderthals produced offspring who inherited vital genes that have helped modern humans combat illness and disease.